📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial. (2022)

First Author: Myring G

Attributed to: The MRC Addiction Research Clinical Training programme: MARC funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2022.09.021

PubMed Identifier: 36170895

Publication URI: http://europepmc.org/abstract/MED/36170895

Type: Journal Article/Review

Volume: 85

Parent Publication: The Journal of infection

Issue: 6

ISSN: 0163-4453